ORMP
Oramed Pharmaceuticals, Inc

4,684
Mkt Cap
$98.41M
Volume
74,371.00
52W High
$3.09
52W Low
$1.82
PE Ratio
2.32
ORMP Fundamentals
Price
$2.33
Prev Close
$2.40
Open
$2.35
50D MA
$2.38
Beta
0.53
Avg. Volume
118,039.83
EPS (Annual)
-$0.4668
P/B
0.47
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives Oramed Releases Letter to...
PR Newswire·23d ago
News Placeholder
More News
News Placeholder
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin Oramed Announces Transformative Joint Venture to Accelerate Development and...
PR Newswire·9mo ago
News Placeholder
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt PR Newswire NEW YORK, Oct. 7, 2024 NEW...
PR Newswire·1y ago
News Placeholder
Oramed Letter to Shareholders
Oramed Letter to Shareholders Oramed Letter to Shareholders PR Newswire NEW YORK, June 26, 2024 Stock Repurchase Program Scilex Senior Secured NotePhase 3 Oral Insulin Trial in USJV with Chinese...
PR Newswire·1y ago
News Placeholder
Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock
Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock PR Newswire NEW YORK, June 26, 2024 NEW YORK, June 26...
PR Newswire·1y ago
News Placeholder
Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation
PALO ALTO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, Scilex ), an innovative revenue-generating company focused on acquiring, developing and commercializing...
Globe Newswire·2y ago
News Placeholder
Oramed Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
Oramed Pharmaceuticals ( NASDAQ:ORMP ) Full Year 2023 Results Key Financial Results Net income: US$5.53m (up from...
Simply Wall St·2y ago
News Placeholder
Oramed Pharmaceuticals (ORMP, $3.24) Aroon Indicator entered an Uptrend on March 04, 2024.
Over the last three days, A.I.dvisor has detected that ORMP's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...
Tickeron - Stocks·2y ago
News Placeholder
Oramed Pharmaceuticals (ORMP, $3.43) Aroon Indicator entered an Uptrend on March 01, 2024.
Over the last three days, A.I.dvisor has detected that ORMP's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...
Tickeron - Stocks·2y ago
News Placeholder
Oramed Pharmaceuticals (ORMP, $3.28) Aroon Indicator entered an Uptrend on February 29, 2024.
Over the last three days, A.I.dvisor has detected that ORMP's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...
Tickeron - Technical Analysis·2y ago

Latest ORMP News

View

Advertisement|Remove ads.

Advertisement|Remove ads.